GlassScriptPhysician profile
Amy Ray Davidson
NPI 1194393991
$1,874.73
in general payments reported to CMS, 2019-2025
20 companies · $560 in 2025
The $560 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $613 · 2023: $164 · 2024: $413 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,136.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $265.23 | 2023-2025 | |
| Medtronic, INC. | $214.96 | 2022-2023 | Corevalve Evolut R |
| Penumbra, INC. | $152.07 | 2025 | Penumbra System |
| E.R. Squibb & Sons, L.L.C. | $149.75 | 2022-2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $139.46 | 2021-2025 | Farxiga |
| Boston Scientific Corporation | $131.00 | 2022 | |
| Abiomed | $118.55 | 2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.08 | 2023-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.29 | 2022 | |
| Kestra Medical Technology Services, INC. | $93.42 | 2025 | Assure Wcd |
| Pfizer INC. | $72.31 | 2023-2025 | |
| Cardiovascular Systems INC. | $64.13 | 2022 | |
| Stryker Corporation | $49.78 | 2024 | Prime |
| Merck Sharp & Dohme LLC | $47.63 | 2023-2025 | Verquvo |
| Amgen INC. | $41.95 | 2023-2025 | Repatha, Repatha |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $34.69 | 2024 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $31.89 | 2024 | |
| Edwards Lifesciences Corporation | $22.31 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Actelion Pharmaceuticals US, INC. | $17.77 | 2025 | Uptravi, Opsumit |
| Lexicon Pharmaceuticals, INC. | $17.46 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.